STATEN ISLAND, New York, June 13, 2025 ( GLOBE NEWSWIRE ) -- Coffee Holding Co., Inc. ( Nasdaq: JVA ) ( the "Company," "our" or "we" ) announced its operating results for the fiscal quarter ended April 30, 2025.

Joshua Brown names Kinsale Capital as his final trade. Kevin Simpson says Jabil surged to a 52-week high. Historic Summer Setup: 3 "Power Patterns" Triggering in the next 75 Days - Get The Details Now

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Jefferies analyst Roger Song downgraded the rating for CureVac N.V.

OMA SAVINGS BANK PLC, STOCK EXCHANGE RELEASE 13 JUNE 2025 AT 15:40 P.M. EET, MAJOR SHAREHOLDER ANNOUNCEMENT ...

As of June 13, 2025, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go ...

Arm CEO joined Nvidia in slamming U.S. sanctions on China, warning they risk stalling tech progress and hurting global consumers. Haas stressed Arm's China ties and said sanctions may fuel China's chip growth, costing Nvidia $8B and hurting U.S. interests.

The global crypto market cap is down 3.9% to $3.25 trillion in a single day. Traders see Bitcoin stuck in a macro range between $101K-$110K, while Ethereum presents a buy-the-dip opportunity. 9 Out of the Last 10 Summers this "Power Pattern" Delivered Winners - Get The Details Now.

A more conservative goal of $100 monthly dividend income would require 361 shares of Microsoft. An investor would need to own $865,318 worth of Microsoft to generate a monthly dividend income of $500. 3 Summer "Power Patterns" Are About to Trigger ( One With 90% Win Rate ) - Get The Details Now

CEO Elon Musk has announced the launch date for Tesla Inc.'s TSLA long-anticipated robotaxi service in Austin, Texas, on June 22, but experts are skeptical over its success.

- Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma - - Rademikibart reduced annualized exacerbations in patients with eosinophilic-driven type 2 asthma - - Data supports ongoing Phase 2 acute exacerbation studies in asthma ...